Cabenuva HIV Drug From GlaxoSmithKline Gets FDA Approval
SUMMARY – Last year, GlaxoSmithKline’s ViiV Healthcare’s feat of getting a long-awaited approval of HIV treatment by the name of Cabenuva was…
SUMMARY – Last year, GlaxoSmithKline’s ViiV Healthcare’s feat of getting a long-awaited approval of HIV treatment by the name of Cabenuva was…
Summary – – Tiziana is Developing the First Oral Form of Foralumab in a Convenient Capsule to be Evaluated in Phase 1b…
Summary : Liver cancer, also known as hepatic cancer and primary hepatic cancer, is a relatively rare form of cancer that has…
Synopsis : mdgroup, the leading global provider of personalised clinical study services, has appointed Dr Arthur Lazarus as Medical Director. Dr Lazarus…
Synopsis : ION Geophysical Corporation (NYSE: IO) today announced that it received notice on January 31, 2022 from the New York Stock…
Summary : FDA approves Enjaymo™ (sutimlimab-jome), first treatment for use in patients with cold agglutinin disease Enjaymo is the only approved treatment…
Synopsis : Yumanity Therapeutics (NASDAQ: YMTX), a clinical-stage biopharmaceutical company focused on the discovery and development of innovative, disease-modifying therapies for neurodegenerative…
Synopsis : Sanofi has been a global healthcare leader that has brought forth treatments for rare diseases and established standard-of-care therapeutics for…
Synopsis : Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, and Pfizer Inc. (NYSE: PFE) today reported further positive…
Summary : Scientists from Ludwig-Maximilians-Universitaet (LMU) in Munich, Helmholtz Munich, and Technical University of Munich have shown that the immune system is…